Premenstrual syndrome and use of psychoactive substances

A CLINICAL EPIDEMIOLOGICAL INVESTIGATION ON THE CO-OCCURRENCE OF PREMENSTRUAL SYNDROME (PMS) AND SUBSTANCE USE DISORDERS ( SUD ) .

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON21106

Enrollment

300

Registered

2018-10-04

Start date

2019-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PMD Premenstrual Disorders PMS Premenstrual syndrome PMDD Premenstrual dysphoric disorders Substance related disorders

Interventions

This is an non-intervention study

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria : • Women between the ages of 18 and 45 • The ability to understand and sign written informed consent

Exclusion criteria

Exclusion criteria: Recent history of clinically significant psychiatric illness including any psychotic disorder e.g. schizophrenia, bipolar disorder or severe depression, suicidal ideation, menopause.

Design outcomes

Primary

Measure	Time frame
association between level of PMS signs and symptoms and level of problematic use of psychoactive substances	—

Secondary

Measure	Time frame
craving for psychoactive substances in relation to PMS sign and symptoms	—

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)